Induce cancer cell hep g2 cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Hep G2 Cells Tumor Cells, Cultured Cell Line, Tumor HCT116 Cells MCF-7 Cells HT29 Cells Cell Line Neoplastic Stem Cells Breast Prostate Epithelial Cells Cell Nucleus Liver Mitochondria HeLa Cells Neoplastic Cells, Circulating Spheroids, Cellular

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases38

Breast Neoplasms Colonic Neoplasms Neoplasm Invasiveness Liver Neoplasms Ovarian Neoplasms Carcinoma, Hepatocellular Neoplasms Lung Neoplasms Pancreatic Neoplasms Neoplasm Metastasis Stomach Neoplasms Prostatic Neoplasms Carcinoma Colorectal Neoplasms Adenocarcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Uterine Cervical Neoplasms Disease Progression Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Endometrial Neoplasms Genetic Predisposition to Disease Neovascularization, Pathologic Carcinoma, Small Cell Bone Neoplasms Esophageal Neoplasms Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Neoplasms, Glandular and Epithelial Rectal Neoplasms Mouth Neoplasms Head and Neck Neoplasms Carcinoma, Pancreatic Ductal Neoplasms, Experimental Neoplastic Cells, Circulating Thyroid Neoplasms

Chemicals and Drugs90

Antineoplastic Agents RNA, Messenger RNA, Small Interfering Neoplasm Proteins Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptors, Estrogen Receptor, erbB-2 Tumor Markers, Biological DNA, Neoplasm Proto-Oncogene Proteins c-akt Hempa Cancer Vaccines RNA, Neoplasm Tamoxifen Cisplatin Receptor, Epidermal Growth Factor Receptors, Androgen Transcription Factors Anticarcinogenic Agents Paclitaxel MicroRNAs Androgens Tumor Suppressor Proteins DNA-Binding Proteins Proto-Oncogene Proteins c-bcl-2 Estrogen Receptor alpha Proto-Oncogene Proteins Enzyme Inhibitors Antigens, Neoplasm Prostate-Specific Antigen Apoptosis Regulatory Proteins Caspase 3 Protein-Serine-Threonine Kinases Caspases Fluorouracil Antibodies, Monoclonal Protein Kinase Inhibitors Receptors, Progesterone Antimetabolites, Antineoplastic Antineoplastic Agents, Hormonal Inhibitor of Apoptosis Proteins Antibiotics, Antineoplastic beta Catenin Estrogens Nuclear Proteins Propyl Gallate Cadherins Cyclin-Dependent Kinase Inhibitor p21 Estrogen Antagonists Phosphatidylinositol 3-Kinases Estradiol Plant Extracts Reactive Oxygen Species Cyclin D1 Cell Cycle Proteins Emetics DNA Primers Quinazolines Carrier Proteins Hydroxamic Acids Membrane Proteins Deoxycytidine TNF-Related Apoptosis-Inducing Ligand Poly(ADP-ribose) Polymerases bcl-2-Associated X Protein Lovastatin Azacitidine NF-kappa B Estrogen Receptor Modulators Histone Deacetylase Inhibitors Indoles Cyclooxygenase 2 Glycoproteins TOR Serine-Threonine Kinases Taxoids Plasminogen Inactivators Antibodies, Monoclonal, Humanized Vascular Endothelial Growth Factor A PTEN Phosphohydrolase Antigens, CD44 Telomerase Recombinant Proteins Proto-Oncogene Proteins c-myc Extracellular Signal-Regulated MAP Kinases Nitriles DNA STAT3 Transcription Factor Radiation-Sensitizing Agents Curcumin

Analytical, Diagnostic and Therapeutic Techniques and Equipment48

Early Detection of Cancer Blotting, Western Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Drug Screening Assays, Antitumor Transfection Neoplasm Transplantation Transplantation, Heterologous Gene Expression Profiling Gene Knockdown Techniques Flow Cytometry Antineoplastic Combined Chemotherapy Protocols Prognosis Oligonucleotide Array Sequence Analysis Tumor Burden Survival Analysis Immunohistochemistry Inhibitory Concentration 50 Survival Rate Molecular Targeted Therapy Models, Biological Neoplasm Staging Tumor Stem Cell Assay Risk Follow-Up Studies Retrospective Studies Combined Modality Therapy Real-Time Polymerase Chain Reaction Registries Mammary Neoplasms, Experimental Prospective Studies Genetic Therapy Immunoblotting Disease-Free Survival Blotting, Northern Risk Assessment Drug Delivery Systems Immunoenzyme Techniques Tissue Array Analysis Sensitivity and Specificity Kaplan-Meier Estimate Chemotherapy, Adjuvant Immunoprecipitation Odds Ratio Neoplasms, Experimental Multivariate Analysis Reproducibility of Results Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes56

Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Drug Resistance, Neoplasm Cell Survival Transfection Cell Division Cell Movement Signal Transduction Down-Regulation Cell Cycle RNA Interference Cell Growth Processes Promoter Regions, Genetic Dose-Response Relationship, Drug Up-Regulation Gene Silencing Phosphorylation Drug Synergism Base Sequence Mutation Transcription, Genetic Gene Expression Inhibitory Concentration 50 Genetic Predisposition to Disease Epithelial-Mesenchymal Transition Enzyme Activation Genes, Tumor Suppressor Cell Adhesion Risk Cell Death Radiation Tolerance Tumor Microenvironment Time Factors Phenotype Protein Binding DNA Damage Genes, Neoplasm Genes, p53 Sensitivity and Specificity Kinetics Transcriptional Activation Odds Ratio Gene Amplification Genes, BRCA1 Epigenesis, Genetic Amino Acid Sequence DNA Methylation Autophagy Genotype Gene Expression Regulation Drug Resistance, Multiple Genetic Vectors MAP Kinase Signaling System Gene Expression Regulation, Enzymologic Cell Cycle Checkpoints

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Base Sequence Molecular Sequence Data Survival Rate Registries Amino Acid Sequence

Named Groups1

Health Care16

Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Follow-Up Studies Retrospective Studies Registries Prospective Studies Disease-Free Survival Risk Assessment Sensitivity and Specificity Kaplan-Meier Estimate Age Factors Odds Ratio Multivariate Analysis Reproducibility of Results

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hep G2 Cells Breast Neoplasms Tumor Cells, Cultured Gene Expression Regulation, Neoplastic Cell Line, Tumor Apoptosis Colonic Neoplasms Cell Proliferation Mice, Nude Antineoplastic Agents Neoplasm Invasiveness Liver Neoplasms Ovarian Neoplasms Carcinoma, Hepatocellular Neoplasms Lung Neoplasms RNA, Messenger Early Detection of Cancer Pancreatic Neoplasms Drug Resistance, Neoplasm Cell Survival RNA, Small Interfering Neoplasm Metastasis Stomach Neoplasms Blotting, Western Neoplasm Proteins Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Drug Screening Assays, Antitumor Transfection Cell Division Cell Movement Signal Transduction Down-Regulation Cell Cycle Antineoplastic Agents, Phytogenic Neoplasm Transplantation HCT116 Cells MCF-7 Cells RNA Interference Cell Growth Processes Transplantation, Heterologous HT29 Cells Promoter Regions, Genetic Prostatic Neoplasms Cell Line Gene Expression Profiling Tumor Suppressor Protein p53 Dose-Response Relationship, Drug Carcinoma Colorectal Neoplasms Adenocarcinoma Receptors, Estrogen Receptor, erbB-2 Urinary Bladder Neoplasms Up-Regulation Tumor Markers, Biological Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Gene Silencing Gene Knockdown Techniques Uterine Cervical Neoplasms Phosphorylation DNA, Neoplasm Drug Synergism Disease Progression Base Sequence Proto-Oncogene Proteins c-akt Hempa Flow Cytometry Cancer Vaccines Mutation Transcription, Genetic RNA, Neoplasm Carcinoma, Squamous Cell Tamoxifen Molecular Sequence Data Cisplatin Receptor, Epidermal Growth Factor Antineoplastic Combined Chemotherapy Protocols Mice, SCID Neoplastic Stem Cells Prognosis Neoplasms, Hormone-Dependent Gene Expression Oligonucleotide Array Sequence Analysis Receptors, Androgen Transcription Factors Tumor Burden Anticarcinogenic Agents Paclitaxel MicroRNAs Survival Analysis Androgens Tumor Suppressor Proteins DNA-Binding Proteins Immunohistochemistry Inhibitory Concentration 50 Survival Rate Proto-Oncogene Proteins c-bcl-2

No FAQ available that match "induce cancer cell hep g2 cells"